RC
CSBR icon

Roubaix Capital’s Champions Oncology CSBR Stock Holding History

Roubaix Capital’s Portfolio CSBR Stock Details CSBR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-351,507
Closed -$3.61M – 43
2021
Q2 		$3.61M Buy
351,507
+72,209
+26% +$732K 2.26% 17
2021
Q1 		$3.16M Buy
279,298
+72,796
+35% +$845K 2.13% 20
2020
Q4 		$2.23M Buy
+206,502
New +$2.13M 1.72% 32

Other funds holding CSBR

BMC
Battery Management Corp Boston, Massachusetts $426M AUM 21.5% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MAG
Millrace Asset Group Berwyn, Pennsylvania $98.4M AUM 63.71% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Roubaix Capital's CSBR Position: Q3 2021 in Review

Roubaix Capital sold out of Champions Oncology (CSBR) in Q3 2021, closing a stake of 351,507 shares — an estimated $3.61M sold.

Roubaix Capital first reported a position in CSBR in Q4 2020 and held it in 3 quarters. The position peaked at $3.61M in Q2 2021. 35 funds tracked by Wall St. Rank hold CSBR as of Q3 2021.

  • Roubaix Capital reported no remaining Champions Oncology position as of Q3 2021 after selling out during the quarter.
  • Roubaix Capital sold 351,507 Champions Oncology shares in Q3 2021, an estimated $3.61M.
  • Roubaix Capital first reported a position in Champions Oncology in Q4 2020 and held it in 3 quarters.
  • Roubaix Capital's Champions Oncology position peaked at $3.61M in Q2 2021.
  • 35 funds tracked by Wall St. Rank held Champions Oncology as of Q3 2021.

Based on Roubaix Capital's 13F filing for Q3 2021, filed 18 Oct 2021.